Hongjun Yue
About Hongjun Yue
Hongjun Yue is a Principal Scientist at IGM Biosciences, Inc., where he focuses on analytical methods and formulation development. He has a Ph.D. in Physical Chemistry from the University of Pittsburgh and extensive experience in antibody structural characterization using Mass Spectrometry.
Work at IGM Biosciences
Hongjun Yue has been serving as a Principal Scientist at IGM Biosciences, Inc. since 2021. In this role, he focuses on the development of analytical methods and formulation development. Prior to his current position, he worked as a Senior Scientist at the same company from 2018 to 2020. His work at IGM Biosciences is based in Mountain View, California, where he applies his expertise in antibody structural characterization using Mass Spectrometry.
Education and Expertise
Hongjun Yue earned his Ph.D. in Physical Chemistry from the University of Pittsburgh, where he studied from 2002 to 2007. He also completed postdoctoral research at The Pennsylvania State University, specializing in Biochemistry and Biophysics. His postdoctoral work included research in Single Molecule Biophysics and Enzymology, further enhancing his scientific expertise. He has extensive experience in managing contract research organizations (CROs) and technical writing.
Background
Hongjun Yue's academic journey began at the University of Pittsburgh, where he conducted research in the Lab of Dr. David H. Waldeck. After completing his doctoral studies, he transitioned to The Pennsylvania State University as a Postdoctoral Research Fellow, working in the labs of Dr. Tae-Hee Lee and Dr. Stephen J. Benkovic. His research experience spans multiple disciplines, contributing to his current role in the biotechnology sector.
Achievements
Hongjun Yue has made significant contributions to the field of analytical chemistry and biophysics. His work includes the development of standard operating procedures (SOPs) and technology transfer documents, which are essential for maintaining quality and compliance in research environments. He specializes in antibody structural characterization using Mass Spectrometry, a critical area in the development of therapeutic antibodies.